128 related articles for article (PubMed ID: 10336239)
1. Effect of a micronized purified flavonoid fraction on in vivo platelet functions in the rat.
McGregor L; Bellangeon M; Chignier E; Lerond L; Rousselle C; McGregor JL
Thromb Res; 1999 May; 94(4):235-40. PubMed ID: 10336239
[TBL] [Abstract][Full Text] [Related]
2. Different flavonoids present in the micronized purified flavonoid fraction (Daflon 500 mg) contribute to its anti-hyperpermeability effect in the hamster cheek pouch microcirculation.
Paysant J; Sansilvestri-Morel P; Bouskela E; Verbeuren TJ
Int Angiol; 2008 Feb; 27(1):81-5. PubMed ID: 18277344
[TBL] [Abstract][Full Text] [Related]
3. Protective Effects of Micronized Purified Flavonoid Fraction (MPFF) on a Novel Experimental Model of Chronic Venous Hypertension.
das Graças C de Souza M; Cyrino FZ; de Carvalho JJ; Blanc-Guillemaud V; Bouskela E
Eur J Vasc Endovasc Surg; 2018 May; 55(5):694-702. PubMed ID: 29588131
[TBL] [Abstract][Full Text] [Related]
4. Diosmin/hesperidin: a cooperating tandem, or is diosmin crucial and hesperidin an inactive ingredient only?
Karetová D; Suchopár J; Bultas J
Vnitr Lek; 2020; 66(2):97-103. PubMed ID: 32942884
[TBL] [Abstract][Full Text] [Related]
5. Anti-platelet effects of yuzu extract and its component.
Yu HY; Park SW; Chung IM; Jung YS
Food Chem Toxicol; 2011 Dec; 49(12):3018-24. PubMed ID: 22005257
[TBL] [Abstract][Full Text] [Related]
6. Antagonism of the GPIIb/IIIa receptor with the nonpeptidic molecule BIBU52: inhibition of platelet aggregation in vitro and antithrombotic efficacy in vivo.
Guth BD; Seewaldt-Becker E; Himmelsbach F; Weisenberger H; Müller TH
J Cardiovasc Pharmacol; 1997 Aug; 30(2):261-72. PubMed ID: 9269956
[TBL] [Abstract][Full Text] [Related]
7. An additional mechanism of action of abciximab: dispersal of newly formed platelet aggregates.
Marciniak SJ; Mascelli MA; Furman MI; Michelson AD; Jakubowski JA; Jordan RE; Marchese PJ; Frelinger AL
Thromb Haemost; 2002 Jun; 87(6):1020-5. PubMed ID: 12083481
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of rat platelet aggregation by mycalolide-B, a novel inhibitor of actin polymerization with a different mechanism of action from cytochalasin-D.
Sugidachi A; Ogawa T; Asai F; Saito S; Ozaki H; Fusetani N; Karaki H; Koike H
Thromb Haemost; 1998 Mar; 79(3):614-9. PubMed ID: 9531051
[TBL] [Abstract][Full Text] [Related]
9. Disaggregatory effects of prostaglandin E1, amrinone and milrinone on platelet aggregation in human whole blood.
Kikura M; Kazama T; Ikeda T; Sato S
Platelets; 2000 Dec; 11(8):446-58. PubMed ID: 11177444
[TBL] [Abstract][Full Text] [Related]
10. Effect of naftazone on in vivo platelet function in the rat.
McGregor L; Chignier E; Bloy C; Rousselle C; Peltier-Pujol F; McGregor JL
Platelets; 1999; 10(1):66-70. PubMed ID: 16801074
[TBL] [Abstract][Full Text] [Related]
11. The thienopyridine PCR 4099 selectively inhibits ADP-induced platelet aggregation and fibrinogen binding without modifying the membrane glycoprotein IIb-IIIa complex in rat and in man.
Gachet C; Stierlé A; Cazenave JP; Ohlmann P; Lanza F; Bouloux C; Maffrand JP
Biochem Pharmacol; 1990 Jul; 40(2):229-38. PubMed ID: 2375765
[TBL] [Abstract][Full Text] [Related]
12. Effects of oral administration of purified micronized flavonoid fraction on increased microvascular permeability induced by various agents and on ischemia/reperfusion in the hamster cheek pouch.
Bouskela E; Donyo KA
Angiology; 1997 May; 48(5):391-9. PubMed ID: 9158383
[TBL] [Abstract][Full Text] [Related]
13. Platelet aggregation and fibrinogen binding in human, rhesus monkey, guinea-pig, hamster and rat blood: activation by ADP and a thrombin receptor peptide and inhibition by glycoprotein IIb/IIIa antagonists.
Cook NS; Zerwes HG; Tapparelli C; Powling M; Singh J; Metternich R; Hagenbach A
Thromb Haemost; 1993 Sep; 70(3):531-9. PubMed ID: 8259560
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of platelet aggregation by some flavonoids.
Tzeng SH; Ko WC; Ko FN; Teng CM
Thromb Res; 1991 Oct; 64(1):91-100. PubMed ID: 1776142
[TBL] [Abstract][Full Text] [Related]
15. A flavonoid fraction purified from Rutaceae aurantiae (Daflon(R)) inhibiting AGE formation, reduces urinary albumin clearance and corrects hypoalbuminemia in normotensive and hypertensive diabetic rats.
Urios P; Kassab I; Grigorova-Borsos AM; Guillot R; Jacolot P; Tessier F; Peyroux J; Sternberg M
Diabetes Res Clin Pract; 2014 Sep; 105(3):373-81. PubMed ID: 24956965
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of platelet aggregation in whole blood by alcohol.
Torres Duarte AP; Dong QS; Young J; Abi-Younes S; Myers AK
Thromb Res; 1995 Apr; 78(2):107-15. PubMed ID: 7482428
[TBL] [Abstract][Full Text] [Related]
17. Effect of long-term treatment with a purified micronized flavonoid fraction on pancreatic mononuclear cell infiltration in diabetic BB rats.
Guillot R; Ogneva V; Hadjiisky P; Kassab JP; Andre J; Mozère G; Peyroux J; Sternberg M
Pancreas; 1998 Oct; 17(3):301-8. PubMed ID: 9788546
[TBL] [Abstract][Full Text] [Related]
18. The effects of doxycycline and micronized purified flavonoid fraction on human vein wall remodeling are not hypoxia-inducible factor pathway-dependent.
Lim CS; Kiriakidis S; Paleolog EM; Davies AH
J Vasc Surg; 2012 Oct; 56(4):1069-77. PubMed ID: 22677007
[TBL] [Abstract][Full Text] [Related]
19. Antithrombotic activity of Vitis labrusca extract on rat platelet aggregation.
Kwon SU; Lee HY; Xin M; Ji SJ; Cho HK; Kim DS; Kim DK; Lee YM
Blood Coagul Fibrinolysis; 2016 Mar; 27(2):141-6. PubMed ID: 26340455
[TBL] [Abstract][Full Text] [Related]
20. Endothelin-1 inhibits platelet aggregation in vivo: a study with 111indium-labelled platelets.
Thiemermann C; May GR; Page CP; Vane JR
Br J Pharmacol; 1990 Feb; 99(2):303-8. PubMed ID: 2183912
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
